Quantitative Models in Life Science Business: From Value Creation to Business Processes (SpringerBriefs in Economics)

This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. 

The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries. 

Philipp Mekler is trained in both biochemistry and mathematics; he has 40+ years of experience in the Pharma/Life Science sector in R&D, sales/marketing, business analysis and bio-business finance/venture capital in CH/US/IL. Currently, he is working as a strategic advisor at the Roche Pharma International Data and Analytics chapter in Basel, Switzerland.

Gang Mu is a visiting research scholar at the University of Zurich, Switzerland and former head of Artificial Intelligence for partnership at Roche, Basel. He holds a Ph.D. degree in mathematics and has comprehensive experience in connecting mathematics, health care and technology, driving impacts and outcomes for patients and healthcare systems. He is the founder of Swiss Network for Mathematics in Industry.